Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Trial: Aspirin After Preeclampsia
NCT06281665Phase 4Recruiting
- Start
- May 2024
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in preeclampsia. Started May 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06281665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06281665.